GSK Seeks To Halt Boehringer Promos That 'Denigrate' Effectiveness Of Ellipta, Diskus Inhalers

 
• By Brenda Sandburg
  
Young female in white t-shirt using medicine dry powder inhaler for treatment asthma/COPD diseases. Pharmaceutical product is used to treat lung inflammation and prevent asthma attack. Close up. - Image
GlaxoSmithKline seeks injunction to halt Boehringer marketing claims about its COPD inhalers
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance